Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X
Signal Transduct Target Ther. 2025; 10(1):57.
PMID: 39979279
PMC: 11842613.
DOI: 10.1038/s41392-025-02148-4.
Tanzhu G, Chen L, Ning J, Xue W, Wang C, Xiao G
MedComm (2020). 2024; 6(1):e70020.
PMID: 39712454
PMC: 11661909.
DOI: 10.1002/mco2.70020.
Moawad A, Janas A, Baid U, Ramakrishnan D, Saluja R, Ashraf N
ArXiv. 2023; .
PMID: 37396600
PMC: 10312806.
Chen J, Williams M, Huang Y, Si S
Front Mol Biosci. 2022; 9:858577.
PMID: 35720132
PMC: 9201447.
DOI: 10.3389/fmolb.2022.858577.
Tas Z, Kulahci O
Cureus. 2022; 14(2):e22151.
PMID: 35308701
PMC: 8920798.
DOI: 10.7759/cureus.22151.
Predicting response to radiotherapy of intracranial metastases with hyperpolarized [Formula: see text]C MRI.
Lee C, Soliman H, Bragagnolo N, Sahgal A, Geraghty B, Chen A
J Neurooncol. 2021; 152(3):551-557.
PMID: 33740165
PMC: 8084843.
DOI: 10.1007/s11060-021-03725-7.
Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors.
Lauko A, Lo A, Ahluwalia M, Lathia J
Semin Cancer Biol. 2021; 82:162-175.
PMID: 33640445
PMC: 9618157.
DOI: 10.1016/j.semcancer.2021.02.014.
Inflammatory lesions and brain tumors: is it possible to differentiate them based on texture features in magnetic resonance imaging?.
Alves A, de Arruda Miranda J, Reis F, de Souza S, Alves L, Feitoza L
J Venom Anim Toxins Incl Trop Dis. 2020; 26:e20200011.
PMID: 32952531
PMC: 7473508.
DOI: 10.1590/1678-9199-JVATITD-2020-0011.
Medical management of brain metastases.
Lauko A, Rauf Y, Ahluwalia M
Neurooncol Adv. 2020; 2(1):vdaa015.
PMID: 32793881
PMC: 7415253.
DOI: 10.1093/noajnl/vdaa015.
Epidemiologic and histologic characteristics of CNS lesions: a 20-year experience of a tertiary center in Lebanon.
Eid R, Hage S, Antonios I, Moussa R, Khoury M, Haddad F
CNS Oncol. 2020; 9(2):CNS55.
PMID: 32603607
PMC: 7341156.
DOI: 10.2217/cns-2020-0001.
Epidemiology of synchronous brain metastases.
Singh R, Stoltzfus K, Chen H, Louie A, Lehrer E, Horn S
Neurooncol Adv. 2020; 2(1):vdaa041.
PMID: 32363344
PMC: 7182307.
DOI: 10.1093/noajnl/vdaa041.
Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine.
Wank M, Schilling D, Schmid T, Meyer B, Gempt J, Barz M
Cancers (Basel). 2018; 10(11).
PMID: 30463322
PMC: 6266328.
DOI: 10.3390/cancers10110456.
Emerging findings into molecular mechanism of brain metastasis.
Ni W, Chen W, Lu Y
Cancer Med. 2018; 7(8):3820-3833.
PMID: 29992751
PMC: 6089171.
DOI: 10.1002/cam4.1667.
Brain metastases epidemiology in a Tunisian population: trends and outcome.
Benna M, Mejri N, Mabrouk M, El Benna H, Labidi S, Daoud N
CNS Oncol. 2018; 7(1):35-39.
PMID: 29347839
PMC: 6001562.
DOI: 10.2217/cns-2017-0020.
Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases.
Chen T, da Fonseca C, Schonthal A
Int J Mol Sci. 2016; 17(9).
PMID: 27598140
PMC: 5037741.
DOI: 10.3390/ijms17091463.
Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
Goncalves P, Peterson S, Vigneau F, Shore R, Quarshie W, Islam K
Cancer. 2016; 122(12):1921-7.
PMID: 27062154
PMC: 4892979.
DOI: 10.1002/cncr.30000.
Epidemiologic and molecular prognostic review of glioblastoma.
Thakkar J, Dolecek T, Horbinski C, Ostrom Q, Lightner D, Barnholtz-Sloan J
Cancer Epidemiol Biomarkers Prev. 2014; 23(10):1985-96.
PMID: 25053711
PMC: 4185005.
DOI: 10.1158/1055-9965.EPI-14-0275.
Incidence of brain metastasis at initial presentation of lung cancer.
Villano J, Durbin E, Normandeau C, Thakkar J, Moirangthem V, Davis F
Neuro Oncol. 2014; 17(1):122-8.
PMID: 24891450
PMC: 4483041.
DOI: 10.1093/neuonc/nou099.
Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.
Spanberger T, Berghoff A, Dinhof C, Ilhan-Mutlu A, Magerle M, Hutterer M
Clin Exp Metastasis. 2012; 30(4):357-68.
PMID: 23076770
DOI: 10.1007/s10585-012-9542-9.
Epidemiology of brain metastases.
Nayak L, Quant Lee E, Wen P
Curr Oncol Rep. 2011; 14(1):48-54.
PMID: 22012633
DOI: 10.1007/s11912-011-0203-y.